Dr. Nedzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1457 Goodbar Ave
Memphis, TN 38104Phone+1 504-296-8656Fax+1 214-645-9233
Summary
- I received a Bachelor of Arts degree in chemistry and physics from Harvard College, magna cum laude, in 1980, a Master of Science degree in applied physics from Stanford University in 1983 and my M.D. degree from the University of California at San Francisco in 1987. I completed residency training at the Joint Center for Radiation Therapy at the Harvard Medical School in Boston, Massachusetts in 1992, serving as chief resident during my final residency year. I was assistant professor of radiation oncology at the University of Southern California in Los Angeles from 1992-1995 and practiced in Los Angeles with Valley Radiotherapy Associates in the 1990’s. I transitioned back to academic practice at Tulane University in New Orleans in 2000 before joining the radiation oncology faculty at UT Southwestern Medical Center in 2008 as an associate professor of radiation oncology.
I have clinical interests and experience in stereotactic radiosurgery(SRS) and body radiotherapy(SBRT), skull base and central nervous system tumors in adults and children and radiotherapy for head and neck cancers. I was the principal investigator of several clinical trials in head and neck squamous cell carcinomas , including published phase I/II trials of weekly cisplatin, cetuximab and nab-paclitaxel with radiotherapy and weekly cisplatin and cetuximab with continuous course re-irradiation and an ongoing phase I radiation dose-escalation trial of SRS without whole brain radiation for brain metastases.
Over the past twenty years, I accrued to RTOG, COG and NRG cooperative group trials and was local principal investigator for the RTOG at Tulane University and UTSouthwestern from 2006-2012. I co-authored published results of RTOG-0320 in brain metastases, RTOG-0617 in lung cancer and many case reports and mentored medical students and residents in clinical research in head and neck cancer, brain tumors and clinical physics.
Education & Training
- Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1988 - 1992
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1987 - 1988
- University of California San Francisco School of MedicineClass of 1987
- Harvard UniversityBA, Chemistry and Physics, Magna Cum Laude, Phi Beta Kappa, 1976 - 1980
Certifications & Licensure
- CA State Medical License 1990 - 2026
- TN State Medical License 1996 - 2026
- TX State Medical License 2008 - 2026
- MS State Medical License 2023 - 2025
- LA State Medical License 2000 - 2020
- MA State Medical License 1989 - 1998
- MN State Medical License 1994 - 1998
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Start of enrollment: 2008 Dec 01
- RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
- Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 206 citationsA Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer ...Paul W. Sperduto, Meihua Wang, H. Ian Robins, Michael C. Schell, Maria Werner-Wasik
International Journal of Radiation Oncology, Biology, Physics. 2013-04-01 - 666 citationsConsolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.Puneeth Iyengar, Zabi Wardak, David E. Gerber, Vasu Tumati, Chul Ahn
JAMA Oncology. 2018-01-11 - 14 citationsComparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysisDavid J. Sher, David L. Schwartz, Lucien A. Nedzi, Saad A. Khan, Randall S. Hughes
Oral Oncology. 2016-03-01
Journal Articles
- Neoadjuvant Stereotactic Radiosurgery Prior to Surgical Resection of Cerebral MetastasesLucien Nedzi, Samuel L Barnett, Tu Dan, Toral R Patel, World Neurosurgery
Press Mentions
- Lucien A. Nedzi, MD, a Radiation Oncologist with UT Southwestern Medical CenterSeptember 9th, 2019
- Multidisciplinary Care Improves Outcomes of Patients with Brain MetastasesDecember 5th, 2018
- Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: